Specific eradication of HIV-1 from infected cultured cells

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Levin, Aviad ^a   Hayouka, Zvi ^a   Friedler, Assaf ^a   Loyter, Abraham ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 16; CASPASE 3; COMPLEMENTARY DNA; GAG PROTEIN; INTEGRASE INHIBITOR; PROTEINASE INHIBITOR; RO 318959; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VIRION; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS PARTICLE;

EID: 77955686538     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-7-31     Document Type: Article

References (41)

1. Robb ML. Failure of the Merck HIV vaccine: an uncertain step forward. Lancet 2008, 372:1857-1858. 10.1016/S0140-6736(08)61593-7, 19012958.
2. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997, 337:734-739. 10.1056/NEJM199709113371102, 9287228.
3. Lalezari JP, Henry K, O'Hearn M, Montaner JS, Piliero PJ, Trottier B, Walmsley S, Cohen C, Kuritzkes DR, Eron JJ, et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med 2003, 348:2175-2185. 10.1056/NEJMoa035026, 12637625.
4. Chene G, Sterne JA, May M, Costagliola D, Ledergerber B, Phillips AN, Dabis F, Lundgren J, D'Arminio Monforte A, de Wolf F, et al. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet 2003, 362:679-686. 10.1016/S0140-6736(03)14229-8, 12957089.
5. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860. 10.1056/NEJM199803263381301, 9516219.
6. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?. AIDS 2003, 17:711-720. 10.1097/00002030-200303280-00009, 12646794.
7. Fan H, Conner RF, Villarreal LP. AIDS: science and society 2005, Jones and Bartlett Publishers, 4.
8. Chiu YL, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, Greene WC. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435:108-114. 10.1038/nature03493, 15829920.
9. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 1998, 4:72-77. 10.1038/nm0198-072, 9427609.
10. Hauber I, Bevec D, Heukeshoven J, Kratzer F, Horn F, Choidas A, Harrer T, Hauber J. Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest 2005, 115:76-85. 539192, 15630446.
11. Hazuda DJ, Young SD, Guare JP, Anthony NJ, Gomez RP, Wai JS, Vacca JP, Handt L, Motzel SL, Klein HJ, et al. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 2004, 305:528-532. 10.1126/science.1098632, 15247437.
12. Huthoff H, Malim MH. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins. Virology 2005, 334:147-153. 10.1016/j.virol.2005.01.038, 15780864.
13. Perros M. CCR5 antagonists for the treatment of HIV infection and AIDS. Advances in Antiviral Drug Design 2007, 5:185-212. De Clercq E.
14. De Clercq E. The history of antiretrovirals: key discoveries over the past 25 years. Rev Med Virol 2009, 19:287-299. 10.1002/rmv.624, 19714702.
15. Pommier Y, Johnson AA, Marchand C. Integrase inhibitors to treat HIV/AIDS. Nat Rev Drug Discov 2005, 4:236-248. 10.1038/nrd1660, 15729361.
16. Cane PA. New developments in HIV drug resistance. J Antimicrob Chemother 2009, 64(Suppl 1):i37-40. 10.1093/jac/dkp258, 19675018.
17. De Clercq E. The acyclic nucleoside phosphonates from inception to clinical use: historical perspective. Antiviral Res 2007, 75:1-13. 10.1016/j.antiviral.2006.10.006, 17116336.
18. DeJesus E, Berger D, Markowitz M, Cohen C, Hawkins T, Ruane P, Elion R, Farthing C, Zhong L, Cheng AK, et al. Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients. J Acquir Immune Defic Syndr 2006, 43:1-5. 10.1097/01.qai.0000233308.82860.2f, 16936557.
19. Steigbigel RT, Cooper DA, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Gatell JM, Rockstroh JK, et al. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med 2008, 359:339-354. 10.1056/NEJMoa0708975, 18650512.
20. Engelman A. AIDS/HIV. A reversal of fortune in HIV-1 integration. Science 2007, 316:1855-1857. 10.1126/science.1145015, 17600205.
21. Sarkar I, Hauber I, Hauber J, Buchholz F. HIV-1 proviral DNA excision using an evolved recombinase. Science 2007, 316:1912-1915. 10.1126/science.1141453, 17600219.
22. Butler SL, Hansen MS, Bushman FD. A quantitative assay for HIV DNA integration in vivo. Nat Med 2001, 7:631-634. 10.1038/87979, 11329067.
23. Gelderblom HC, Vatakis DN, Burke SA, Lawrie SD, Bristol GC, Levy DN. Viral complementation allows HIV-1 replication without integration. Retrovirology 2008, 5:60. 10.1186/1742-4690-5-60, 2474848, 18613957.
24. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188. 10.1038/387183a0, 9144289.
25. Levin A, Hayouka Z, Brack-Werner R, Volsky DJ, Friedler A, Loyter A. Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration. Protein Eng Des Sel 2009, 22:753-763. 10.1093/protein/gzp060, 19875511.
26. Levin A, Hayouka Z, Friedler A, Brack-Werner R, Volsky DJ, Loyter A. A novel role for the viral Rev protein in promoting resistance to Super-infection by Human Immunodeficiency Virus type 1. J Gen Virol 2010, 91:1503-1513. 10.1099/vir.0.019760-0, 20147519.
27. Levin A, Hayouka Z, Friedler A, Loyter A. Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein. Nucleus 2010, 1. 2898211, 20617112., http://www.landesbioscience.com/journals/nucleus/article/11300/
28. Levin A, Hayouka Z, Helfer M, Brack-Werner R, Friedler A, Loyter A. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration. PLoS ONE 2009, 4:e4155. 10.1371/journal.pone.0004155, 2607543, 19127291.
29. Levin A, Rosenbluh J, Hayouka Z, Friedler A, Loyter A. Integration of HIV-1 DNA is regulated by interplay between viral Rev and cellular LEDGF/p75 proteins. Mol Med 2010, 16:34-44. 10.2119/molmed.2009.00133, 2765407, 19855849.
30. Rosenbluh J, Hayouka Z, Loya S, Levin A, Armon-Omer A, Britan E, Hizi A, Kotler M, Friedler A, Loyter A. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides. J Biol Chem 2007, 282:15743-15753. 10.1074/jbc.M609864200, 17403681.
31. Levin A, Hayouka Z, Helfer M, Brack-Werner R, Friedler A, Loyter A. Stimulation of the HIV-1 Integrase Enzymatic Activity and cDNA Integration by a Peptide Derived from the Integrase Protein. Biopolymers 2010, 93:740-751.
32. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, Fischer U, Meese E, Wain-Hobson S, Meyerhans A. Multiply infected spleen cells in HIV patients. Nature 2002, 418:144. 10.1038/418144a, 12110879.
33. Roberts NA, Craig JC, Duncan IB. HIV proteinase inhibitors. Biochem Soc Trans 1992, 20:513-516.
34. Sarojini H, Medepalli K, Terry DA, Alphenaar BW, Wang E. Localized delivery of DNA to the cells by viral collagen-loaded silica colloidal crystals. Biotechniques 2007, 43:213-214. 216-218, 220-211, 10.2144/000112493, 17824389.
35. Mizushima N, Kuma A, Kobayashi Y, Yamamoto A, Matsubae M, Takao T, Natsume T, Ohsumi Y, Yoshimori T. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci 2003, 116:1679-1688. 10.1242/jcs.00381, 12665549.
36. Cavin LG, Venkatraman M, Factor VM, Kaur S, Schroeder I, Mercurio F, Beg AA, Thorgeirsson SS, Arsura M. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis. Cancer Res 2004, 64:7030-7038. 10.1158/0008-5472.CAN-04-1647, 15466196.
37. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992, 66:2232-2239. 289016, 1548759.
38. Pizzato M, Erlwein O, Bonsall D, Kaye S, Muir D, McClure MO. A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. J Virol Methods 2009, 156:1-7. 10.1016/j.jviromet.2008.10.012, 19022294.
39. Casabianca A, Gori C, Orlandi C, Forbici F, Federico Perno C, Magnani M. Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay. Mol Cell Probes 2007, 21:368-378. 10.1016/j.mcp.2007.05.005, 17629450.
40. Levin A, Hayouka Z, Friedler A, Loyter A. Over expression of the HIV-1 Rev promotes death of non-dividing eukaryotic cells. Virus Genes 2010, 40:341-346. 10.1007/s11262-010-0458-7, 20151187.
41. Aquaro S, Muscoli C, Ranazzi A, Pollicita M, Granato T, Masuelli L, Modesti A, Perno CF, Mollace V. The contribution of peroxynitrite generation in HIV replication in human primary macrophages. Retrovirology 2007, 4:76. 10.1186/1742-4690-4-76, 2173904, 17949509.